ArticleArchives of toxicology2025
2,2',4,4'-tetrabromodiphenyl ether (BDE-47) induces early hearing loss in guinea pigs via activating AhR to trigger mitochondrial and endoplasmic reticulum stress-regulated autophagy.
Article in Archives of toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Transcriptomics and metabolomics reveal functional nanoplastics-induced male reproductive damage and resveratrol antagonistic effects.Journal of nanobiotechnology · 2026Article
- Autophagy in Sensorineural Hearing Loss: Jekyll or Hyde?International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
2,2',4,4'-tetrabromodiphenyl ether (BDE-47) is a ubiquitous environmental pollutant linked to early neurotoxicity, but its effects on hearing loss during early development remain unclear. We exposed weanling guinea pigs to BDE-47 (1, 10, 50 mg/kg/day) via gavage for 28 days, finding increased hearing thresholds at 0.5 and 4 kHz, hair cell damage, and elevated AhR, LC3B, and P-SQSTM1 levels. In vitro, BDE-47 reduced HEI-OC1 cell viability dose dependently, increasing AhR, oxidative stress (MitoTracker, MitoSOX, ROS), and activating the Keap1-Nrf2 antioxidant pathway. Elevated autophagosomes, P-SQSTM1 and LC3B-II, were observed, indicating autophagic flux inhibition. The AhR inhibitor CH223191 mitigated these effects, while Mdivi-1 (mitochondrial division inhibitor) reduced ROS and autophagy, suggesting AhR promotes mitochondrial oxidative stress, impairing autophagy. BDE-47 also increased ER-Tracker fluorescence, reduced lysosomes, and altered UPR markers (Calnexin, PDI, IRE1-α, Bip, Erol-α, PERK, and Chop), most of which were attenuated by CH223191. The ER stress inhibitor TUDCA further alleviated ROS, Keap1-Nrf2 dysregulation, and autophagy disruption. Our findings demonstrate that early BDE-47 exposure induces hearing impairment via AhR-mediated mitochondrial oxidative stress and ER stress, suppressing autophagy. These findings enhance our understanding of environmental chemical-induced ototoxicity and provide valuable insights for both auditory disorder risk assessment and therapeutic strategies for hearing preservation.
Indexed as
Identifiers
40835755What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.